RO7490677

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7490677, covering 2022-01-05 to 2022-01-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of RO7490677 In Participants With Myelofibrosis [Phase 2]